$8.43
+0.130 (+1.57%)
At Close: Jun 23, 2026
Kymera Therapeutics Begins U.S. IPO Effort (Private:KYTX)
08:38pm, Wednesday, 05'th Aug 2020
Kymera Therapeutics has filed to raise $100 million in an IPO, although the final figure may vary. The firm is advancing drug treatment candidates for skin conditions and cancers.
Sign In
Buy KYTX